期刊文献+

奥利司他中间体利普司他汀标准品的制备工艺研究 被引量:1

Study on the Preparation Technology of the Lipstatin Standard Products
下载PDF
导出
摘要 目的本文主要发明了一种利普司他汀对照标准品的制备工艺。方法本法先采用了DAC50 C_8制备柱(50mm×450mm,5μm),以86%甲醇-RO水溶液为流动相,上柱液浓度21000μg·mL^(-1),进样量1.4g·L^(-1),检测波长195nm,上柱流速为35mL·min^(-1),洗脱流速为50mL·min^(-1),得到了组分含量超过93%的收集液。再将收集液加入庚烷萃取,后在庚烷相中加入乙腈萃取至乙腈相,减压浓缩。结果得到纯度93%相对含量为85%的利普司他汀标准品。结论本工艺可制备得到可应用于利普司他汀检测的合格标准品。 OBJECTIVE The present invention provides a method for preparing(purifying)standard products of Lipstatin.METHODS The separation was performed on DAC50 C 8 column(50mm×450mm,5μm).The mobile phase was 86%methanol-water solution,the injection volume(sample load)was 1.4g·L-1,and detection wavelength was 195nm,load sample flow was 35mL·min-1,elution flow was 50mL·min-1,the composition of collected sample was over 93%.The collected sample was extracted with heptane,and separated by partitioning.Then add acetonitrile in the heptane solution.RESULTS The aceronitrile solution was concentrated by reducing pressure,concentrate of Lipstatin was obtained.CONCLUSION This method can prepare the standard products of Lipstatin.
作者 孔腾腾 陈斌 褚少青 李宏杰 KONG Teng-teng;CHEN Bin;CHU Shao-qing;LI Hong-jie(Hangzhou Zhongmei Huadong Pharmaceutical Co.,Ltd,Hangzhou 310000,China)
出处 《海峡药学》 2019年第2期69-71,共3页 Strait Pharmaceutical Journal
关键词 DAC50制备柱 制备 收集 萃取 浓缩 标准品 DAC50 prepare column Preparation Collection Extraction Concentration Standard products
  • 相关文献

参考文献2

二级参考文献14

  • 1李淑珍,李进,杨志江,原惠.大孔树脂分离纯化黑果枸杞总黄酮的研究[J].食品科学,2009,30(1):19-24. 被引量:53
  • 2Greenway FL,Caruso MK.Safety of obesity drugs[J].Expert Opin Drug Safety,2005,4(6):1083-1095.
  • 3Hochuli E,Kupfer E,Maurer R,et al.Lipstatin,an inhibitor of pancreatic lipase,produced by Streptomyces toxytricini.II.Chemistry and structure elucidation[J].J Antibiot (tokyo),1987,40(8):1086-1091.
  • 4Weibel EK,Hadvary P,Hochuli E,et al.Lipstatin,an inhibitor of pancreatic lipase,produced by Streptomyces toxytricini.I.Producing organism,fermentation,isolation and biological activity[J].J Antibiot (Tokyo),1987,40(8):1081-1085.
  • 5Paul H,Erich H,Ernst K,et al.Leucine derivatives:EP,129748[P].1985-01-02;US,4598089[P].1986-06-01.(CA1985,103:52722)
  • 6Weatherburn MW.Phenol-hypochlorite reaction for determination of ammonia[J].Anal Chem,1967,39(8):971-974.
  • 7Janos E,Eva G,Gabor B,et al.Fermentation process for lipstatin and method of extracting lipstatin from a fermentation broth:US,6844174[P].2005-01-18.
  • 8Schuhr CA,Eisenreich W,Goese M,et al.Biosynthetic precursors of the lipase inhibitor lipstatin[J].J Org Chem,2002,67(7):2257-2262.
  • 9Large KP,Mirjalili N,Peacock MOLM.et al.Lipase activity in Streptomycetes[J].Enzyme Microb Technol,1999,25(7):569-575.
  • 10Whitlock G, Lewington S. , et al. Body- mass indexand cause - specific mortality in 900,000 adults : collaborative analyses of 57 prospective studies[ J ]. The Lancet. 2009, 373 (9669) - 1 083 - 96.

共引文献10

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部